These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37767104)

  • 1. The association of upper respiratory infections with neuro-radiological course and attack rate of multiple sclerosis: Results from a large prospective cohort.
    Ghasemi M; Farazandeh D; Amini B; Sedaghat M; Najafi A; Khayatzadeh Kakhki S; Torabi P; Jafarimehrabady N; Bitaraf A; Shariati H; Gholampour G; Kazemi S; Naser Moghadasi A; Vajihinejad M
    Mult Scler J Exp Transl Clin; 2023; 9(3):20552173231196992. PubMed ID: 37767104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of infection on exacerbations of multiple sclerosis.
    Panitch HS
    Ann Neurol; 1994; 36 Suppl(Suppl):S25-8. PubMed ID: 8017885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis attacks are associated with picornavirus infections.
    Kriesel JD; White A; Hayden FG; Spruance SL; Petajan J
    Mult Scler; 2004 Apr; 10(2):145-8. PubMed ID: 15124758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study.
    Vercellino M; Bosa C; Alteno A; Muccio F; Marasciulo S; Garelli P; Cavalla P
    Mult Scler Relat Disord; 2023 Jun; 74():104715. PubMed ID: 37058763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
    Kneider M; Lisovskaja V; Lycke J; Malmeström C; Jakobsen JK; Nerman O; Andersen O
    Neuroepidemiology; 2015; 45(2):83-9. PubMed ID: 26316226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study on the relationship between infections and multiple sclerosis exacerbations.
    Buljevac D; Flach HZ; Hop WC; Hijdra D; Laman JD; Savelkoul HF; van Der Meché FG; van Doorn PA; Hintzen RQ
    Brain; 2002 May; 125(Pt 5):952-60. PubMed ID: 11960885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study.
    Barzegar M; Vaheb S; Mirmosayyeb O; Afshari-Safavi A; Nehzat N; Shaygannejad V
    Mult Scler Relat Disord; 2021 Jul; 52():102947. PubMed ID: 33979771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocrelizumab for multiple sclerosis.
    Lin M; Zhang J; Zhang Y; Luo J; Shi S
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013247. PubMed ID: 35583174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective cohort study of leukotriene receptor antagonist therapy for preventing upper respiratory infection-induced acute asthma exacerbations.
    Matsuse H; Tsuchida T; Fukahori S; Kawano T; Tomari S; Matsuo N; Nishino T; Fukushima C; Kohno S
    Allergy Rhinol (Providence); 2013; 4(3):e127-31. PubMed ID: 24498517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab for multiple sclerosis.
    Riera R; Porfírio GJ; Torloni MR
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011203. PubMed ID: 27082500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siponimod for multiple sclerosis.
    Cao L; Li M; Yao L; Yan P; Wang X; Yang Z; Lao Y; Li H; Yang K; Li K
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013647. PubMed ID: 34783010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.
    Rahmani M; Moghadasi AN; Shahi S; Eskandarieh S; Azizi H; Hasanzadeh A; Ahmadzade A; Dehnavi AZ; Farahani RH; Aminianfar M; Naeini AR
    Med Clin (Barc); 2023 Mar; 160(5):187-192. PubMed ID: 36089420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod for relapsing-remitting multiple sclerosis.
    La Mantia L; Tramacere I; Firwana B; Pacchetti I; Palumbo R; Filippini G
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD009371. PubMed ID: 27091121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis.
    Edwards S; Zvartau M; Clarke H; Irving W; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):736-41. PubMed ID: 9647301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?
    Etemadifar M; Sedaghat N; Aghababaee A; Kargaran PK; Maracy MR; Ganjalikhani-Hakemi M; Rayani M; Abhari AP; Khorvash R; Salari M; Nouri H
    Mult Scler Relat Disord; 2021 Jun; 51():102915. PubMed ID: 33799284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study.
    Rahmani M; Moghadasi AN; Shahi S; Eskandarieh S; Azizi H; Hasanzadeh A; Ahmadzade A; Dehnavi AZ; Farahani RH; Aminianfar M; Naeini AR
    Med Clin (Engl Ed); 2023 Mar; 160(5):187-192. PubMed ID: 36883067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
    Fitzgerald KC; Munger KL; Köchert K; Arnason BG; Comi G; Cook S; Goodin DS; Filippi M; Hartung HP; Jeffery DR; O'Connor P; Suarez G; Sandbrink R; Kappos L; Pohl C; Ascherio A
    JAMA Neurol; 2015 Dec; 72(12):1458-65. PubMed ID: 26458124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C; Zeng Z; Wang B; Guo S
    J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 triggered relapse of multiple sclerosis.
    Finsterer J
    Clin Neurol Neurosurg; 2022 Apr; 215():107210. PubMed ID: 35305393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.